Health status of patients with ankylosing spondylitis: A comparison with the population

Annals of the Rheumatic Diseases

Volumn 63, Issue 12, 2004, Pages 1605-1610

  Dagfinrud, H ^a   Mengshoel, A M ^a   Hagen, K B ^b   Loge, J H ^a   Kvien, T K ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b DIAKONHJEMMET HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACADEMIC ACHIEVEMENT; ADULT; AGE; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; CONTROLLED STUDY; EMOTION; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; NORWAY; PAIN; PHYSICAL ACTIVITY; POPULATION; PRIORITY JOURNAL; SEX; SOCIAL ASPECT; STATISTICAL ANALYSIS;

ADULT; AGE FACTORS; EDUCATIONAL STATUS; FEMALE; HEALTH STATUS; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SPONDYLITIS, ANKYLOSING;

EID: 9644264135     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2003.019224     Document Type: Article

References (49)

1. Robbins L, Burckhardt CS, Hannan MT. Clinical care, 2nd ed. Atlanta, Georgia: ACR, 2001.
2. Silman A, Hochberg MC, eds. Epidemiology of rheumatic diseases, 2nd ed. Oxford: Oxford University Press, 2001.
3. Gran JT, Husby G. The epidemiology of ankylosing spondylitis. Semin Arthritis Rheum 1993;22:319-24.
4. Will R, Edmunds L, Elswood J, Calin A. Is there sexual inequality in ankylosing spondylitis? A study of 498 women and 1202 men. J Rheumatol 1990;17:1649-52.
5. van der Linden S, van der Heijde D. Ankylosing spondylitis. Clinical features. Rheum Dis Clin North Am. 1998;24:663-76, vii).
6. Khan M. Ankylosing spondylitis. In: Klippel JH, Dieppe PA, eds. Rheumatology. London: Mosby, 1994.
7. Schumacher R, Klippel JH, Koopman W. Primer on the rheumatic diseases. Atlanta: Arthritis Foundation, 1993.
8. Gran JT, Husby G. Ankylosing spondylitis in women. Semin Arthritis Rheum 1990;19:303-12.
9. Kidd B, Mullee M, Frank A, Cawley M. Disease expression of ankylosing spondylitis in males and females. J Rheumatol 1988;15:1407-9.
10. Eustace S, Coughlan RJ, McCarthy C. Ankylosing spondylitis. A comporison of clinical and radiographic features in men and women. Ir Med J 1993;86:120-2.
11. Dougados M, Revel M, Khan MA. Spondylarthropothy treatment: progress in medical treatment, physical therapy and rehabilitation, Baillieres Clin Rheumatol 1998;12:717-36.
12. Marshall RW, Kirwan JR. Methotrexate in the treatment of ankylosing spondylitis. Stand J Rheumatol 2001;30:313-14.
13. Brandt J, Khariouzov A, Listing J, Haibel H, Sorensen H, Grassnickel L, et al. Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis. Arthritis Rheum 2003;48:1667-75.
14. Braun J, Brandt J, Listing J, Rudwaleit M, Sieper J. Biologic therapies in the spondyloarthritis: new opportunities, new challenges. Curr Opin Rheumatol 2003;15:394-407.
15. Lee HS, Kim TH, Yun HR, Park YW, Jung SS, Bae SC, et al. Radiologic changes of cervical spine in ankylosing spondylitis. Clin Rheumatol 2001;20:262-6.
16. Cerrahglu L, Unlu M. Lumbar stiffness but not thoracic radiographic changes relate to alteration of lung function test in AS. Clin Rheumatol 2002;21:275-9.
17. Gran JT, Husby G. Clinical, epidemiologic, and therapeutic aspects of ankylosing spondylitis. Curr Opin Rheumatol 1998;10:292-8.
18. WHO. The international classification of functioning, disability and health 2001.
19. Svenaeus F. The hermeneutics of medicine and the phenomenology of health: steps towards a philosophy of medical practice. Dordrecht, The Netherlands: Kluwer, 1999.
20. Ware JE Jr. Using generic measures of functional health and well-being to increase understanding of disease burden. Spine 2000;25:1467.
21. Moll JM. New criteria for the diagnosis of ankylosing spondylitis. Scand J Rheumatol Suppl 1987;65:12-24.
22. Loge JH, Kaasa S. Short form 36 (SF-36) health survey: normative data from the general Norwegian population. Scand J Soc Med 1998;26:250-8.
23. Loge JH. Health-related quality of life in Hodgkin's disease survivors-methodological and clinical issues. Oslo: University of Oslo, 1999.
24. Ware JE Jr. The SF-36 Health Survey. In: Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials. Philadelphia: Lippincott-Raven, 1996:337-43.
25. Hagen KB, Smedstad LM, Uhlig T, Kvien TK. The responsiveness of health status measures in patients with rheumatoid arthritis: comparison of disease-specific and generic instruments. J Rheumatol 1999;26:1474-80.
26. Hays RD, Hahn H, Marshall G. Use of the SF-36 and other health-related quality of life measures to assess persons with disabilities. Arch Phys Med Rehabil 2002;83(suppl 2):S4-9.
27. Kvien TK, Kaasa S, Smedstad LM. Performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. II. A comparison of the SF-36 with disease-specific measures. J Clin Epidemiol 1998;51:1077-86.
28. van der Heijde, Bellamy N, Calin A, Dougados M, Khan MA, van der Linden S. Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group. J Rheumatol 1997;24:2225-9.
29. van der Heijde, Calin A, Dougados M, Khan MA, van der LS, Bellamy N. Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis. J Rheumatol 1999;26:951-4.
30. van der Heijde D, van der Linden S, Bellamy N, Calin A, Dougados M, et al. Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV. J Rheumatol 1999;26:945-7.
31. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
32. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21:2281-5.
33. Jones SD, Steiner A, Garrett SL, Calin A. The Bath Ankylosing Spondylitis Patient Global Score (BAS-G). Br J Rheumatol 1996;35:66-71.
34. Cohen J. Statistical power analysis for the behavioral sciences - the effect size. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.
35. Carette S, Graham D, Little H, Rubenstein J, Rosen P. The natural disease course of ankylosing spondylitis. Arthritis Rheum 1983;26:186-90.
36. Amor B, Santos RS, Nahal R, Listrat V, Dougados M. Predictive factors for the longterm outcome of spondyloarthropathies. J Rheumatol 1994;21:1883-7.
37. Braunstein EM, Martel W, Moidel R. Ankylosing spondylitis in men and women: a clinical and radiographic comparison. Radiology 1982;144:91-4.
38. Jimenez-Balderas FJ, Mintz G. Ankylosing spondylitis: clinical course in women and men. J Rheumatol 1993;20:2069-72.
39. Ward MM. Health-related quality of life in ankylosing spondylitis: a survey of 175 patients. Arthritis Care Res 1999;12:247-55.
40. Ariza-Ariza R, Hernandez-Cruz B, Navarro-Sarabia F. Physical function and health-related quality of life of Spanish patients with ankylosing spondylitis. Arthritis Rheum 2003;49:483-7.
41. Kvien TK, Uhlig T. The Oslo experience with arthritis registries. Clin Exp Rheumatol 2003;21 (suppl 31): 118-22.
42. Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A. Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 1994;21:1694-8.
43. Doward LC, Spoorenberg A, Cook SA, Whalley D, Helliwell PS, Kay LJ, et al. Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 2003;62:20-6.
44. Spilker B. Quality of life and pharmacoeconomics in clinical trials, 2nd ed. New York: Lippincott-Raven, 1996.
45. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993;118:622-9.
46. Suarez-Almazor ME, Kendall C, Johnson JA, Skeith K, Vincent D. Use of health status measures in patients with low back pain in clinical settings. Comparison of specific, generic and preference-based instruments. Rheumatology (Oxford) 2000;39:783-90.
47. Kvien TK, Kaasa S, Smedstad LM. Performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. II. A comparison of the SF-36 with disease-specific measures. J Clin Epidemiol 1998;51:1077-86.
48. Loge JH, Abrahamsen AF, Ekeberg O, Kaasa S. Reduced health-related quality of life among Hodgkin's disease survivors: a comparative study with general population norms. Ann Oncol 1999;10:71-7.
49. Lydick EG, Epstein R. Clinical significance of quality of life data. In: Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials. Philadelphia: Lippincott-Raven, 1996:461-465.